Amide Bond Activation of Biological Molecules
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
METACYC ID Description A0AR23 GO:0004842 (Ubiquitin-Protein Ligase
Electronic Supplementary Material (ESI) for Integrative Biology This journal is © The Royal Society of Chemistry 2012 Heat Stress Responsive Zostera marina Genes, Southern Population (α=0. -
Covalent and Noncovalent Intermediates of an NAD Utilizing Enzyme, Human CD38
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Chemistry & Biology Article Covalent and Noncovalent Intermediates of an NAD Utilizing Enzyme, Human CD38 Qun Liu,1 Irina A. Kriksunov,1 Hong Jiang,2 Richard Graeff,4 Hening Lin,2 Hon Cheung Lee,4,5,* and Quan Hao1,3,5,* 1MacCHESS, Cornell High Energy Synchrotron Source 2Department of Chemistry and Chemical Biology 3School of Applied & Engineering Physics Cornell University, Ithaca, NY 14853, USA 4Department of Pharmacology, University of Minnesota, Minneapolis, MN 55455, USA 5Department of Physiology, University of Hong Kong, Hong Kong, China *Correspondence: [email protected] (H.C.L.), [email protected] (Q.H.) DOI 10.1016/j.chembiol.2008.08.007 SUMMARY These processes are known to have important cellular and physiological functions in DNA repair (Lombard et al., 2005; Enzymatic utilization of nicotinamide adenine dinu- Michan and Sinclair, 2007), transcriptional regulation (Blander cleotide (NAD) has increasingly been shown to have and Guarente, 2004), cellular differentiation and proliferation, fundamental roles in gene regulation, signal trans- aging (Hassa et al., 2006), and calcium signaling (Lee, 2001; duction, and protein modification. Many of the pro- Lee et al., 1999). cesses require the cleavage of the nicotinamide moi- Although NAD is a substrate for multiple enzymes, the initial ety from the substrate and the formation of a reactive steps of the cleavage and release of the nicotinamide moiety are conserved. The nature of the subsequent intermediates intermediate. Using X-ray crystallography, we show formed, on the other hand, has been a widely debatable issue. -
Recommending Hartree-Fock Theory with London- Dispersion and Basis
Recommending Hartree-Fock Theory with London- Dispersion and Basis-Set-Superposition Corrections for the Optimization or Quantum Refinement of Protein Structures Lars Goerigk,a* Charles A. Collyer,b Jeffrey R. Reimersc,d* a School of Chemistry, The University of Melbourne, Parkville, Victoria 3010, Australia b School of Molecular Bioscience, The University of Sydney, Sydney, New South Wales 2006, Australia c School of Physics and Advanced Materials, The University of Technology, Sydney, NSW 2007, Australia d Centre for Quantum and Molecular Structure, College of Sciences, Shanghai University, Shanghai 200444, China 1 ABSTRACT We demonstrate the importance of properly accounting for London-dispersion and basis-set superposition-error (BSSE) in quantum-chemical optimizations of protein structures, factors that are often still neglected in contemporary applications. We optimize a portion of an ensemble of conformationally flexible lysozyme structures obtained from highly accurate X-ray crystallography data that serves as a reliable benchmark. We not only analyze root-mean-square deviations from the experimental Cartesian coordinates, but, for the first time, also demonstrate how London-dispersion and BSSE influence crystallographic R factors. Our conclusions parallel recent recommendations for the optimization of small gas-phase peptide structures made by some of the present authors: Hartree-Fock theory extended with Grimme’s recent dispersion and BSSE corrections (HF-D3-gCP) is superior to popular density-functional-theory (DFT) approaches. Not only are statistical errors on average lower with HF-D3-gCP, but also its convergence behavior is much better. In particular, we show that the BP86/6-31G* approach should not be relied upon as a black-box method, despite its widespread use, as its success is based on an unpredictable cancellation of errors. -
Amino Acid Building Block Models – in Brief
Amino Acid Building Block Models – In Brief Key Teaching Points for Amino Acid Building Block Models© Overall Student Learning Objective: What Dictates How a Protein Folds? Amino acids are the building blocks of proteins. All amino acids have an identical core structure consisting of an alpha-carbon, carboxyl group, amino group and R-group (sidechain). A linear chain of amino acids is a polypeptide. The primary sequence of a protein is the linear sequence of amino acids in a polypeptide. Proteins are made up of amino acid monomers linked together by peptide bonds. Peptide bond formation between amino acids results in the release of water (dehydration synthesis or condensation reaction). The protein backbone is characterized by the “N-C-C-N-C-C. .” pattern. The “ends” of the protein can be identified by the N-terminus (amino group) end and the C-terminus (carboxyl group) end. For a more complete lesson guide, please visit: http://www.3dmoleculardesigns.com/3DMD-Files/AABB/ContentsandAssembly.pdf Amino Acid Core Structure Build an amino acid according to the diagram to the right: 1. Identify the alpha carbon, amino group, carboxyl group and R-group (sidechain representation) in the structure you have constructed. Two amino acids can be chemically linked by a reaction called “condensation” or “dehydration synthesis” to form a dipeptide bond linking the two amino acids. A chain of amino acid units (monomers) linked together by peptide bonds is called a polypeptide. General Dipeptide Structure Construct a model of a dipeptide using the amino acid models previously built. 2. What are the products of the condensation reaction (dehydration synthesis)? 3. -
Peptide Therapeutics Designing a Science-Led Strategic Quality Control Program
BioProcess International Peptide SPECIAL REPORT Therapeutics Designing a Science-Led Strategic Quality Control Program INTERTEK PHARMACEUTICAL SERVICES Your partner for regulatory-driven, phase appropriate analytical programs tailored to your molecule. Our experts help you to navigate the challenges of development, regulatory submission, and manufacturing. Peptide Therapeutics Designing a Science-Led Strategic Quality Control Program Shashank Sharma and Hannah Lee ince the emergence of peptide therapeutics in the 1920s with the advent of insulin therapy, the market for this product class has continued to expand with global revenues anticipatedS to surpass US$50 billion by 2024 (1). The growth of peptide therapeutics is attributed not only to improvements in manufacturing, but also to a rise in demand because of an increasingly aging population that is driving an increase in the occurrence of long-term diseases. The need for efficient and low-cost drugs and rising investments in research and development of novel drugs continues to boost market growth and fuel the emergence of generic versions that offer patients access to vital medicines at low costs. North America has been the dominant market for peptide therapeutics, with the Asia–Pacific region Insulin molecular model; the first therapeutic expected to grow at a faster rate. The global peptides use of this peptide hormone was in the market has attracted the attention of key players 1920s to treat diabetic patients. within the pharmaceutical industry, including Teva Pharmaceuticals, Eli Lilly, Novo Nordisk, Pfizer, amino acids to be peptides. Within that set, those Takeda, and Amgen. Those companies have made containing 10 or more are classed as polypeptides. -
Amide, and Paratoluenesulfonamide on the Amide of Silver,On the Imides
68 CHEMISTRY: E. C. FRANKLIN METALLIC SALTS OF AMMONO ACIDS By Edward C. Franklin DEPARTMENT OF CHEMISTRY, STANFORD UNIVERSITY Presented to the Academy, January 9. 1915 The Action of Liquid-Ammonia Solutions of Ammono Acids on Metallic Amides, Imides, and Nitrides. The acid amides and imides, and the metallic derivatives of the acid amides and imides are the acds, bases, and salts respectively of an ammonia system of acids, bases, and salts.1 Guided by the relationships implied in the above statement Franklin and Stafford were able to prepare potassium derivatives of a considerable number of acid amides by the action of potassium amide on certain acid amides in solution in liquid ammonia. That is to say, an ammono base, potassium amide, was found to react with ammono acids in liquid ammonia to form ammono salts just as the aquo base, potassium hydrox- ide, acts upon aquo acids in water solution to form aquo salts. Choos- ing, for example, benzamide and benzoic acid as representative acids of the two systems, the analogous reactions taking place respectively in liquid ammonia and water are represented by the equations: CH6CONH2+KNH2 = C6H5CONHK + NHs. CseHCONH2 + 2KNH2 = CIHsCONK2 + 2NH3. CH6tCOOH + KOH = CIH6COOK + H2O. The ammono acid, since it is dibasic, reacts with either one or two molecules of potassium amide to form an acid and a neutral salt. Having thus demonstrated the possibility of preparing ammono salts of potassium by the interaction of potassium amide and acid amides in liquid ammonia solution, it was further found that ammono salts of the heavy metals may be prepared by the action of liquid ammonia solutions of ammono acids on insoluble metallic amides, imides, and nitrides-that is, by reactions which are analogous to the formation of aquo salts in water by the action of potassium hydroxide on insoluble metallic hydroxides and oxides. -
Amide Activation: an Emerging Tool for Chemoselective Synthesis
Featuring work from the research group of Professor As featured in: Nuno Maulide, University of Vienna, Vienna, Austria Amide activation: an emerging tool for chemoselective synthesis Let them stand out of the crowd – Amide activation enables the chemoselective modification of a large variety of molecules while leaving many other functional groups untouched, making it attractive for the synthesis of sophisticated targets. This issue features a review on this emerging field and its application in total synthesis. See Nuno Maulide et al., Chem. Soc. Rev., 2018, 47, 7899. rsc.li/chem-soc-rev Registered charity number: 207890 Chem Soc Rev View Article Online REVIEW ARTICLE View Journal | View Issue Amide activation: an emerging tool for chemoselective synthesis Cite this: Chem. Soc. Rev., 2018, 47,7899 Daniel Kaiser, Adriano Bauer, Miran Lemmerer and Nuno Maulide * It is textbook knowledge that carboxamides benefit from increased stabilisation of the electrophilic carbonyl carbon when compared to other carbonyl and carboxyl derivatives. This results in a considerably reduced reactivity towards nucleophiles. Accordingly, a perception has been developed of amides as significantly less useful functional handles than their ester and acid chloride counterparts. Received 27th April 2018 However, a significant body of research on the selective activation of amides to achieve powerful DOI: 10.1039/c8cs00335a transformations under mild conditions has emerged over the past decades. This review article aims at placing electrophilic amide activation in both a historical context and in that of natural product rsc.li/chem-soc-rev synthesis, highlighting the synthetic applications and the potential of this approach. Creative Commons Attribution 3.0 Unported Licence. -
Reactions of Benzene & Its Derivatives
Organic Lecture Series ReactionsReactions ofof BenzeneBenzene && ItsIts DerivativesDerivatives Chapter 22 1 Organic Lecture Series Reactions of Benzene The most characteristic reaction of aromatic compounds is substitution at a ring carbon: Halogenation: FeCl3 H + Cl2 Cl + HCl Chlorobenzene Nitration: H2 SO4 HNO+ HNO3 2 + H2 O Nitrobenzene 2 Organic Lecture Series Reactions of Benzene Sulfonation: H 2 SO4 HSO+ SO3 3 H Benzenesulfonic acid Alkylation: AlX3 H + RX R + HX An alkylbenzene Acylation: O O AlX H + RCX 3 CR + HX An acylbenzene 3 Organic Lecture Series Carbon-Carbon Bond Formations: R RCl AlCl3 Arenes Alkylbenzenes 4 Organic Lecture Series Electrophilic Aromatic Substitution • Electrophilic aromatic substitution: a reaction in which a hydrogen atom of an aromatic ring is replaced by an electrophile H E + + + E + H • In this section: – several common types of electrophiles – how each is generated – the mechanism by which each replaces hydrogen 5 Organic Lecture Series EAS: General Mechanism • A general mechanism slow, rate + determining H Step 1: H + E+ E El e ctro - Resonance-stabilized phile cation intermediate + H fast Step 2: E + H+ E • Key question: What is the electrophile and how is it generated? 6 Organic Lecture Series + + 7 Organic Lecture Series Chlorination Step 1: formation of a chloronium ion Cl Cl + + - - Cl Cl+ Fe Cl Cl Cl Fe Cl Cl Fe Cl4 Cl Cl Chlorine Ferric chloride A molecular complex An ion pair (a Lewis (a Lewis with a positive charge containing a base) acid) on ch lorine ch loronium ion Step 2: attack of -
Introduction to Proteins and Amino Acids Introduction
Introduction to Proteins and Amino Acids Introduction • Twenty percent of the human body is made up of proteins. Proteins are the large, complex molecules that are critical for normal functioning of cells. • They are essential for the structure, function, and regulation of the body’s tissues and organs. • Proteins are made up of smaller units called amino acids, which are building blocks of proteins. They are attached to one another by peptide bonds forming a long chain of proteins. Amino acid structure and its classification • An amino acid contains both a carboxylic group and an amino group. Amino acids that have an amino group bonded directly to the alpha-carbon are referred to as alpha amino acids. • Every alpha amino acid has a carbon atom, called an alpha carbon, Cα ; bonded to a carboxylic acid, –COOH group; an amino, –NH2 group; a hydrogen atom; and an R group that is unique for every amino acid. Classification of amino acids • There are 20 amino acids. Based on the nature of their ‘R’ group, they are classified based on their polarity as: Classification based on essentiality: Essential amino acids are the amino acids which you need through your diet because your body cannot make them. Whereas non essential amino acids are the amino acids which are not an essential part of your diet because they can be synthesized by your body. Essential Non essential Histidine Alanine Isoleucine Arginine Leucine Aspargine Methionine Aspartate Phenyl alanine Cystine Threonine Glutamic acid Tryptophan Glycine Valine Ornithine Proline Serine Tyrosine Peptide bonds • Amino acids are linked together by ‘amide groups’ called peptide bonds. -
Mechanism of the Cooperative Si–H Bond Activation at Ru–S Bonds† Cite This: Chem
Chemical Science View Article Online EDGE ARTICLE View Journal | View Issue Mechanism of the cooperative Si–H bond activation at Ru–S bonds† Cite this: Chem. Sci.,2015,6,4324 a a ab b Timo Stahl, Peter Hrobarik,´ * C. David F. Konigs,¨ Yasuhiro Ohki, Kazuyuki Tatsumi,b Sebastian Kemper,a Martin Kaupp,a Hendrik F. T. Klare*a and Martin Oestreich*a The nature of the hydrosilane activation mediated by ruthenium(II) thiolate complexes of type [(R3P)- + F À Ru(SDmp)] [BAr 4] is elucidated by an in-depth experimental and theoretical study. The combination of various ruthenium(II) thiolate complexes and tertiary hydrosilanes under variation of the phosphine ligand and the substitution pattern at the silicon atom is investigated, providing detailed insight into the activation mode. The mechanism of action involves reversible heterolytic splitting of the Si–H bond across the polar Ru–S bond without changing the oxidation state of the metal, generating a ruthenium(II) hydride and sulfur-stabilized silicon cations, i.e. metallasilylsulfonium ions. These stable yet highly reactive adducts, which serve as potent silicon electrophiles in various catalytic transformations, are fully Creative Commons Attribution 3.0 Unported Licence. characterized by systematic multinuclear NMR spectroscopy. The structural assignment is further verified by successful isolation and crystallographic characterization of these key intermediates. Quantum- chemical analyses of diverse bonding scenarios are in excellent agreement with the experimental findings. Moreover, the calculations reveal that formation of the hydrosilane adducts proceeds via barrierless electrophilic activation of the hydrosilane by sterically controlled h1 (end-on) or h2 (side-on) coordination of the Si–H bond to the Lewis acidic metal center, followed by heterolytic cleavage of the Received 21st March 2015 Si–H bond through a concerted four-membered transition state. -
FOCUS REVIEW Transition Metal Mediated Cleavage of C-C Bonds
FOCUS REVIEW Transition Metal Mediated Cleavage of C-C Bonds in Aromatic Rings Martin Jakoobi,[a] and Alexey G. Sergeev*[a] [a] Title(s), Initial(s), Surname(s) of Author(s) including Corresponding Author(s) Department Institution Address 1 E-mail: [b] Title(s), Initial(s), Surname(s) of Author(s) Department Institution Address 2 Supporting information for this article is given via a link at the end of For internalthe document. use,((Please please delete dothis textnot if notdelete. appropriate)) Submitted_Manuscript FOCUS REVIEW Abstract: Metal-mediated cleavage of aromatic C-C bonds has a 1.2. Challenges in metal mediated cleavage of aromatic C-C range of potential synthetic applications: from direct coal liquefaction bonds to synthesis of natural products. However, in contrast to the activation of aromatic C-H bonds, which has already been widely In contrast to activation of aromatic C-H bonds, which is now studied and exploited in diverse set of functionalization reactions, widely used in organic synthesis, activation of aromatic C-C cleavage of aromatic C-C bonds is still Terra Incognita. This focus bonds is still a challenging and largely unexplored area.[1, 8] review summarizes the recent progress in this field and outlines key Activation of strong aromatic C-C bonds requires harsh reaction challenges to be overcome to develop synthetic methods based on conditions, and occurs with poor chemoselectivity (C-H bonds this fundamental organometallic transformation. are activated preferentially) and regioselectivity (different kinds of aromatic C-C bonds can be activated indiscriminately), which limits synthetic applications of this promising transformation. The 1. -
Peptides As Drug Candidates: Limitations and Recent Development Perspectives
ISSN: 2574-1241 Volume 5- Issue 4: 2018 DOI: 10.26717/BJSTR.2018.08.001694 Yusuf A Haggaga. Biomed J Sci & Tech Res Mini Rewiew Open Access Peptides as Drug Candidates: Limitations and Recent Development Perspectives Yusuf A. Haggag*1, Ahmed A. Donia1,2, Mohamed A. Osman1, Sanaa A. El-Gizawy1 1Department of Pharmaceutical Technology, Faculty of Pharmacy, Tanta University, Tanta, Egypt 2Department of Pharmaceutical Technology, Faculty of Pharmacy, Menofia University, Menofia, Egypt Received: Published: *Corresponding August author: 28, 2018; September 05, 2018 Yusuf A Haggag, Department of Pharmaceutical Technology, Faculty of Pharmacy, Tanta University, Egypt Abbreviations: GLP-1: Glucagon-Like Peptide-1; PEG: Polyethylene Glycol; Gamma IgG: Immunoglobulin; FcRn: Fc Receptor Introduction [4]. Discovery of several tumor-related peptides and proteins also Peptides can be defined as polypeptide chains of 50 or less protein/peptide receptors is supposed to create a new revolution amino acids or 5000 Da in molecular weight characterized by a wave of more promising, effective and selective anticancer drugs in high degree of secondary structure and lack of tertiary structure. the future. Therapeutic anticancer peptides will capture the largest Therapeutic peptides have traditionally been derived from nature share of the cancer therapeutic market [2]. This mode of cancer as naturally occurring peptide hormones (known as bioactive treatment including peptides, proteins and monoclonal antibodies peptides), genetic/recombinant libraries and chemical libraries is termed “biologics” treatment option [5]. [1]. The recent technologies used for peptides production include chemical synthesis, enzymatic synthesis, recombinant DNA About 75% from the whole peptide drugs in the market that biotechnology, cell-free expression and transgenic animal or plant gained total global sales over $1 billion are used directly in cancer There are several hundred peptide candidates under clinical species.